ProfileGDS4718 / 212050_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 93% 88% 93% 91% 86% 85% 93% 95% 92% 91% 95% 89% 85% 86% 88% 89% 85% 84% 84% 90% 91% 91% 91% 90% 89% 93% 87% 93% 90% 83% 80% 94% 94% 87% 86% 88% 93% 92% 87% 91% 88% 85% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.6241592
GSM549102patient 115, normal, homogenized [OPG study]9.8120793
GSM549104patient 119, normal, homogenized [OPG study]8.937188
GSM549108patient 138, normal, homogenized [OPG study]9.6993793
GSM549119patient 077, normal, homogenized [OPG study]9.3242691
GSM549133patient 032, cancer, homogenized [OPG study]8.6773386
GSM549139patient 042, cancer, homogenized [OPG study]8.5083985
GSM549099patient 107, normal, homogenized [OPG study]9.6623593
GSM549109patient 139, normal, homogenized [OPG study]10.250695
GSM549110patient 046, normal, homogenized [OPG study]9.6117192
GSM549114patient 063, normal, homogenized [OPG study]9.6281291
GSM549122patient 082, normal, homogenized [OPG study]10.252195
GSM549134patient 033, cancer, homogenized [OPG study]9.0881789
GSM549136patient 036, cancer, homogenized [OPG study]8.5451785
GSM549140patient 044, cancer, homogenized [OPG study]8.6717986
GSM549111patient 047, normal, homogenized [OPG study]8.9326488
GSM549113patient 057, normal, homogenized [OPG study]9.2425989
GSM549132patient 031, cancer, homogenized [OPG study]8.5059485
GSM549137patient 038, cancer, homogenized [OPG study]8.377884
GSM549142patient 047, cancer, homogenized [OPG study]7.9637584
GSM549100patient 110, normal, homogenized [OPG study]9.1329590
GSM549107patient 135, normal, homogenized [OPG study]9.5317891
GSM549115patient 068, normal, homogenized [OPG study]9.5563791
GSM549116patient 072, normal, homogenized [OPG study]9.4969791
GSM549120patient 078, normal, homogenized [OPG study]9.2051890
GSM549131patient 030, cancer, homogenized [OPG study]9.1513789
GSM549118patient 074, normal, homogenized [OPG study]9.807393
GSM549129patient 027, cancer, homogenized [OPG study]8.6570487
GSM549123patient 088, normal, homogenized [OPG study]9.8697993
GSM549124patient 006, cancer, homogenized [OPG study]9.0167290
GSM549126patient 015, cancer, homogenized [OPG study]8.24183
GSM549128patient 025, cancer, homogenized [OPG study]7.92880
GSM549103patient 117, normal, homogenized [OPG study]9.9477994
GSM549117patient 073, normal, homogenized [OPG study]10.189794
GSM549138patient 041, cancer, homogenized [OPG study]8.8074587
GSM549141patient 045, cancer, homogenized [OPG study]8.6634386
GSM549130patient 028, cancer, homogenized [OPG study]8.7959788
GSM549101patient 111, normal, homogenized [OPG study]9.6708193
GSM549105patient 128, normal, homogenized [OPG study]9.5983592
GSM549106patient 134, normal, homogenized [OPG study]8.8526887
GSM549112patient 048, normal, homogenized [OPG study]9.4111191
GSM549125patient 011, cancer, homogenized [OPG study]8.7631988
GSM549127patient 024, cancer, homogenized [OPG study]8.4962785
GSM549135patient 035, cancer, homogenized [OPG study]8.6507186